The value of contact tracing and isolation in mitigation of COVID-19 epidemic: findings from outbreak investigation of COVID-19 onboard Nile Cruise Ship, Egypt, March 2020.


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
07 2022
Historique:
received: 02 02 2022
accepted: 21 02 2022
entrez: 15 7 2022
pubmed: 16 7 2022
medline: 20 7 2022
Statut: ppublish

Résumé

WHO informed Egypt health authorities of individuals of different nationalities who proved positive for COVID-19 after returning from Egypt. Patients were among touristic group who visited Cairo and spent 1-week onboard Nile cruise ship. Investigation performed to confirm outbreak, detect source, and implement containment measures. Active case finding and contact tracing performed among contacts of the index cases and their contacts. Contacts defined as anyone within 6 feet from confirmed or suspected COVID-19 case for ≥15 min. Overall, 331 contacts, including 201 ship boarders and 130 hotel guests, were listed and interviewed using semistructured questionnaire and tested for COVID-19 by PCR. Among them, 136 (41.1%) were close contacts of index cases and 195 (58.9%) contacted secondary cases. Their mean age was 34.6±11.5 years, 251 (75.8%) were males and 126 (38.1%) non-Egyptians. Of them, 67 (20.2%) tested positive for COVID-19, including 57 (28.4%) ship boarders and 10 (7.7%) hotel guests. Per cent positive was significantly higher in: contacts of index cases, Egyptians, ship boarders and in males than corresponding categories (35.3% vs 9.7%, 22.9% vs 15.9%, 27.4% vs 7.7%, 24.7% vs 6.3%), respectively. Of all positive cases, 40 (59.7%) were asymptomatic where ship boarders, non-Egyptians, >50 years old and females were more likely to be asymptomatic than corresponding categories (85.0 vs 48.9%, 72.7 vs 54.5%, 100.0 vs 56.5%), respectively. COVID-19 patients among group of tourists triggered an outbreak onboard Nile ship and hotel in Egypt. Outbreak quickly contained through lab testing, case isolation, strict infection control measures and contact tracing which proved effective in reducing COVID-19 transmission early in pandemic.

Identifiants

pubmed: 35840167
pii: bmjgh-2022-008681
doi: 10.1136/bmjgh-2022-008681
pmc: PMC9295195
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Emerg Infect Dis. 2020 Jul;26(7):
pubmed: 32364890
Science. 2020 May 8;368(6491):
pubmed: 32234805
JAMA Netw Open. 2020 May 1;3(5):e2010182
pubmed: 32459353
Lancet Public Health. 2020 Aug;5(8):e452-e459
pubmed: 32682487
Int J Infect Dis. 2020 Aug;97:293-295
pubmed: 32535295
J Med Virol. 2021 Feb;93(2):820-830
pubmed: 32691881
Lancet Infect Dis. 2020 Oct;20(10):1151-1160
pubmed: 32559451
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930

Auteurs

Hossam Hassan (H)

Department of Epidemiology and Surveillance, Preventive Sector, Ministry of Health and Population, Cairo, Egypt dr_hossam987@yahoo.com.

Hanaa Abo ElSood (H)

Department of Epidemiology and Surveillance, Preventive Sector, Ministry of Health and Population, Cairo, Egypt.

Basma Abd ElGawad (B)

Department of Epidemiology and Surveillance, Preventive Sector, Ministry of Health and Population, Cairo, Egypt.

Reham Kamel (R)

Department of Epidemiology and Surveillance, Preventive Sector, Ministry of Health and Population, Cairo, Egypt.

Manal Fahim (M)

Department of Epidemiology and Surveillance, Preventive Sector, Ministry of Health and Population, Cairo, Egypt.

Sahar El Shourbagy (S)

Department of Communicable Diseases Control, Preventive Sector, Ministry of Health and Population, Cairo, Egypt.

Shymaa Showky (S)

Central Public Health Laboratory, Preventive Sector, Ministry of Health and Population, Cairo, Egypt.

Amira Mohsen (A)

National Research Centre, Cairo, Egypt.

Salma Afifi (S)

Preventive Sector, Egypt Ministry of Health and Population, Cairo, Egypt.

Alaa Eid (A)

Preventive Sector, Egypt Ministry of Health and Population, Cairo, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH